Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-09-15), Glucose Health's 5-Day RSI is 56.42.
The industry rank for Glucose Health's 5-Day RSI or its related term are showing as below:
GLUC's 5-Day RSI is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 40.25
vs GLUC: 56.42
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Glucose Health 5-Day RSI Related Terms
GLUC vs RTON, BDPT, SMFL: 5-Day RSI Comparison
For the Packaged Foods subindustry, Glucose Health's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glucose Health 5-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Glucose Health's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Glucose Health's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glucose Health (GLUC) has a 5-Day RSI of 56.42 as of Sep. 15, 2026.
Is Glucose Health's 5-Day RSI too high?
Glucose Health's current 5-Day RSI is 56.42. The Consumer Packaged Goods industry median 5-Day RSI is 40.25. Glucose Health's value of 56.42 is 40.2% above this industry median. Overall, Glucose Health has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Glucose Health's 5-Day RSI compare to RTON and BDPT?
Glucose Health's 5-Day RSI of 56.42 can be compared against companies in the Consumer Packaged Goods industry. The industry median 5-Day RSI is 40.25. Glucose Health's value of 56.42 is 40.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Consumer Packaged Goods company?
The median 5-Day RSI among Consumer Packaged Goods companies is 40.25, based on 2,097 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glucose Health's current 5-Day RSI of 56.42 is 40.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 5-Day RSI is 40.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glucose Health's current 5-Day RSI is 56.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glucose Health stock overvalued right now?
Glucose Health (GLUC) has a current 5-Day RSI of 56.42. The current 5-Day RSI is 56.42 and 40.2% above the Consumer Packaged Goods industry median of 40.25. Glucose Health's overall GF Score™ is 38/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Glucose Health (GLUC), the current 5-Day RSI is 56.42 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glucose Health Inc is an own-label distributor of nutritional beverages. Its niche is the formulation, manufacturing, marketing, and distribution of soluble fiber-infused nutritional beverages. The Company has identified two underserved consumer markets and has launched two brands to serve these markets, which are GlucoDown and FIBER UP. The Company currently has one single operating and reporting segment, which is the manufacturing and distribution of nutritional beverages. It generates all of its revenue from sales of nutritional beverages. The beverages are sold through the Company's website as well as through retailers.
38GF Score
Get the complete analysis for GLUC
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLUC has been successfully added to your 
